공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 의료용 분자진단 시장 분석

Market Analysis on Molecular Diagnostics in Healthcare (pre-order)

리서치사 M14 Intelligence Research Pvt. Ltd.
발행일 On Demand Report 상품 코드 919020
페이지 정보 영문
가격
US $ 6,800 ₩ 7,789,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스로, 인쇄가 불가능한 PDF파일로 제공됩니다.
US $ 8,500 ₩ 9,736,000 PDF (Multi-user License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste, 다운로드 및 인쇄가 가능합니다. 인쇄 횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 의료용 분자진단 시장 분석 Market Analysis on Molecular Diagnostics in Healthcare (pre-order)
발행일 : On Demand Report 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의료용 분자진단(Molecular Diagnostics) 시장에 대해 분석했으며, 시장의 기본 구조와 최근의 변화, 주요 시장 성장 촉진·억제요인, 전체적인 시장 규모 동향 전망, 용도별·기술별·지역별 상세 동향, 대표적인 기술 보급·활용 상황, 최근의 기술 개발/자본 거래 동향, 향후 시장 기회 전망 등의 정보를 정리하여 전해드립니다.

제1장 주요 요약

제2장 분석 범위와 방법

제3장 분자진단 : 업계 동향 변화

  • 정밀의료 업계에서의 분자진단 보급률 상승
  • 기술 진보에 따른 신흥국에서의 분자진단 수요 증가

제4장 의료용 분자진단 시장 : 최근의 유기적·무기적 발전 동향

  • 무기적 발전 : 기업 인수합병(M&A), 투자, 펀딩, 사업 협력

제5장 FDA(미국식품의약국)의 법령과 규제 : 분자진단 시장 성장 억제요인

제6장 분자진단 활용 분야 : 감염증, 종양, 유전자 검사, 혈액 검사

제7장 분자진단 기술 분석

  • PCR(중합효소 연쇄 반응) 기술 : 신속·저가 DNA 증폭 수단
  • FISH(형광동소보합법) : 염색체 내부의 특정 DNA 시퀀스를 탐지하기 위한 방법
  • 시퀀싱(DNA/NGS) : 게노믹스, 프로테오믹스, 트랜스크립토믹스, 메타볼로믹스용 이용
  • 마이크로어레이 기술 : 질환 관련 유전자/병원체 판정(지노타이핑)
  • INAAT(등온 핵산 증폭 기술) : 임상용 거대 수요
  • 기타 : 전기영동, 질량 분석, 유세포 분석

제8장 경쟁력 평가 : 분자진단 시장 경쟁 상황

  • 주요 기업의 제품 및 서비스 : 시장 점유율 분석
  • 각 지역의 시장 점유율 구조
  • 각 기업의 최신 기술 : 분자진단 시장
  • 최근의 자본 거래 동향 : 사업 제휴·협력, 기업 인수합병(M&A), 펀딩 등
  • 주요 분석 대상 기업 : Roche Diagnostics, Qiagen, Becton Dickinson(BD), Abbott Laboratories, Hologic(Gen-Probe 포함), Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated

제9장 부록

KSM 20.01.06

M14 Intelligence expertise in precision medicine industry is a leverage of its multiple years of data-evaluation of emerging healthcare technologies. Our team of 2 consultants and 1 subject matter expert of molecular diagnostic technology has been tracking and evaluation the changing dynamics of the industry.

  • The report gives detailed analysis on the changing dynamics, emerging trends, and market opportunities of molecular diagnostics market.
  • The report covers analysis on historical market trend, and market forecast of molecular diagnostics market.
  • The report analyzes the expected future demand of molecular diagnostics and factors that are defining this expected demand.
  • A deep investigation into Molecular diagnostics industry and detailed analysis on its
  • Applications such as Infectious diseases, Oncology, Genetic Testing, Blood Screening
  • Microbiology and Neurological Diseases.
  • Technology such as- Polymerase Chain Reaction (PCR), Hybridization, Sequencing
  • (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT)

Electrophoresis, Mass spectroscopy, Flow Cytometry. Demand for Molecular diagnostics is analysed across different end users such as hospitals, laboratories, pharmaceuticals and biotechnology industries, clinical diagnostics, centres, universities and research organisations which is mentioned in this report.

Molecular Technologies that are analysed are Polymerase Chain Reactions (PCR), Hybridization, Sequencing (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Electrophoresis, Mass Spectroscopy, Flow Cytometry.

Leading companies and new entrants in the market are analysed for their revenue, product and service offerings.

The detailed survey on inorganic developments such as partnerships, mergers & acquisition, collaboration and organic developments are mentioned in this report.

Companies offering Molecular Diagnostics Technology mentioned in the report are: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic, Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated, Johnson and Johnson, GenMark diagnostics, Alere Inc., Analytik Jena, Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Biocartis Group NV, HiberGene Diagnostics, Celtic Molecular Diagnostics (Pty) Ltd., Laboratory Corporation of America Holdings, DNA Diagnostics Center, Elitechgroup, GE Healthcare, Inc., Genomic Health, Inc., Agendia NV, Luminex Corporation, Oxford Gene Technology, Savyon Diagnostics, Seegene Inc, Transgenomic Inc., Kaneka Eurogentec S.A, Milliporesigma, Myriad Genetics, Inc, Origene Technologies, Inc., Ortho Clinical Diagnostics, Perkinelmer Inc., Promega Corporation, Sorenson Genomics, LLC, Sysmex Inostics GmbH, Wuxi Nextcode, Grifols, Diasorin, 10X Genomics, Bristol-Myers Squibb, Foundation Medicine, HTG Molecular Diagnostics, Merck KGaA, Beckman Coulter Inc., GNA Biosolutions, Asuragen, Inc, AutoGenomics, MolecularMD. The list includes the leading players, new entrants and start-ups.

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Scope and Research Methodology

Chapter 3: Molecular Diagnostics - Changing-Industry Dynamics

  • 3.1. Increasing market penetration of molecular diagnostics in precision medicine industry
  • 3.2. Increasing demand for molecular diagnostics in emerging markets due to advancement in molecular techniques and diagnostics test

Chapter 4: Latest Organic and Inorganic Developments in Molecular Diagnostics in Healthcare

  • Inorganic Developments mentioned in this report are: Acquisitions, Mergers, Investments, Funding and Collaboration

Chapter 5: FDA Rules and Regulations Restraining Factors in Molecular Diagnostics

Chapter 6: Molecular Diagnostics for Applications: Infectious Disease, Oncology, Genetic Testing, Blood Screening

Chapter 7: Molecular Diagnostics Technology Analysis

  • 7.1. Fast and inexpensive polymerase chain reaction (PCR) technology used to amplify small segments of DNA
  • 7.2. Fluorescence in situ hybridization (FISH) a laboratory technique for detecting and locating a specific DNA sequence on a chromosome
  • 7.3. Sequencing (DNA & NGS) including genomics, proteomics, transcriptomics, metabolomics
  • 7.4. Microarray technology used for genotyping and determination of disease-relevant genes or agents causing diseases
  • 7.5. Isothermal Nucleic Acid Amplification Technology (INAAT) high on demand especially for Clinical application
  • 7.6. Other technologies includes: Electrophoresis, Mass spectroscopy and Flow cytometry

Chapter 8: Competition Assessment: Competitive Landscape in Molecular Diagnostics-

  • 8.1. Molecular Diagnostics Market share analysis by Products & Services offered by the Leading Companies
  • 8.2. Region wise market share analysis of Molecular Diagnostics Market
  • 8.3. Latest Technologies offered by the competitors in Molecular Diagnostics Market
  • 8.4. Latest Developments such as partnerships, collaboration, mergers & acquisitions, funding by the competitors in molecular Diagnostics market
  • 8.5. Leading Players in Molecular Diagnostics Market mentioned in report: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic (includes Gen-Probe), Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated

Chapter 9: Appendix

  • 9.1. References
  • 9.2. Excerpt of interviews with leading industry players
Back to Top
전화 문의
F A Q